Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
D015084:2,4-Dichlorophenoxyacetic Acid / Q000494:pharmacology; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001798:Blood Proteins / Q000378:metabolism*; D002374:Catalase / Q000032:analysis; D002994:Clofibrate / Q000494:pharmacology; D003605:D-Amino-Acid Oxidase / Q000032:analysis; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008055:Lipids / Q000097:blood; D008099:Liver / Q000166:cytology* / Q000187:drug effects; D008297:Male; D008930:Mitochondria, Liver / Q000378:metabolism; D009940:Organoids / Q000187:drug effects*; D010088:Oxidoreductases / Q000032:analysis; D011422:Propionates / Q000494:pharmacology*; D011485:Protein Binding; D051381:Rats; D013974:Thyroxine / Q000097:blood* / Q000378:metabolism; D014631:Valerates
D000924:Anticholesteremic Agents; D001798:Blood Proteins; D000960:Hypolipidemic Agents; D008055:Lipids; D011422:Propionates; D014631:Valerates; D015084:2,4-Dichlorophenoxyacetic Acid; D010088:Oxidoreductases; D002374:Catalase; D003605:D-Amino-Acid Oxidase; D002994:Clofibrate; D013974:Thyroxine; D001241:Aspirin